MedPath
HSA Approval

GAVISCON DOUBLE ACTION LIQUID, SUSPENSION

SIN14016P

GAVISCON DOUBLE ACTION LIQUID, SUSPENSION

GAVISCON DOUBLE ACTION LIQUID, SUSPENSION

September 19, 2011

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Therapeutic

General Sale List

Formulation Information

SUSPENSION

**Dosage:** For oral use. Shake well before use. Adults and children over 12 years: Take 10–20ml (Two to four 5ml spoonfuls) after meals and at bedtime, up to four times a day. Children under 12 years: Not to be given unless recommended by your doctor.

ORAL

Medical Information

Gaviscon Double Action Liquid brings relief from the pain and discomfort of heartburn and acid indigestion. It gets to work in two different ways: 1. neutralising excess stomach acid to relieve pain and discomfort. 2. forming a protective barrier over the stomach contents to soothe the burning pain in your chest.

**Before taking this product.** Each 20ml dose contains 11.06 mmol sodium and 6.5 mmol calcium. If you have been advised a diet restricted in any of these please ask your doctor before taking this product. Do not take if you know you are allergic to any of the ingredients as very rarely difficulty in breathing and skin rashes have occurred. Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed). Consult your doctor if you experience these or any other side effects.

A02AD01

ordinary salt combinations

Manufacturer Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER HEALTHCARE (UK) LIMITED

Active Ingredients

SODIUM BICARBONATE

213MG/10ML

Sodium bicarbonate

CALCIUM CARBONATE

325MG/10ML

Calcium carbonate

SODIUM ALGINATE

500MG/10ML

Alginic acid

Documents

Patient Information Leaflets

Gaviscon Double Action Liquid Suspension PIL.pdf

Approved: July 9, 2019

Download
© Copyright 2025. All Rights Reserved by MedPath